Morbidity of CRM Disorders: Multifaceted Risk Factor Management
Industry Podcast Series Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Not for CME/CE Credit
Cardiometabolic risk factors can contribute to the development and progression of CRM disorders. Listen as two key experts discuss the impact of coexisting CRM disorders on morbidity, and how healthcare providers can manage these disorders through collaborative care.
This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.